Marla J. Keller

4.8k total citations
93 papers, 3.1k citations indexed

About

Marla J. Keller is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Marla J. Keller has authored 93 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Epidemiology, 43 papers in Microbiology and 36 papers in Infectious Diseases. Recurrent topics in Marla J. Keller's work include Reproductive tract infections research (42 papers), HIV/AIDS Research and Interventions (25 papers) and Herpesvirus Infections and Treatments (24 papers). Marla J. Keller is often cited by papers focused on Reproductive tract infections research (42 papers), HIV/AIDS Research and Interventions (25 papers) and Herpesvirus Infections and Treatments (24 papers). Marla J. Keller collaborates with scholars based in United States, Canada and United Kingdom. Marla J. Keller's co-authors include Betsy C. Herold, Natalia Cheshenko, Benjamin Galen, Esmeralda Guzman, Pedro M. M. Mesquita, Rebecca Pellett Madan, Albert T. Profy, Mary E. Klotman, Robert I. Lehrer and Sylvan Wallenstein and has published in prestigious journals such as JAMA, Nature Immunology and The Journal of Immunology.

In The Last Decade

Marla J. Keller

90 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marla J. Keller United States 33 1.3k 1.1k 1.1k 609 558 93 3.1k
Jo‐Ann S. Passmore South Africa 34 823 0.6× 1.6k 1.4× 1.3k 1.2× 770 1.3× 986 1.8× 119 3.4k
Adam Burgener Canada 24 654 0.5× 957 0.8× 671 0.6× 721 1.2× 574 1.0× 73 2.3k
Heather B. Jaspan South Africa 32 920 0.7× 972 0.9× 1.0k 1.0× 325 0.5× 620 1.1× 130 3.1k
J. Neil Simonsen Canada 24 1.2k 1.0× 963 0.8× 857 0.8× 705 1.2× 488 0.9× 37 3.2k
Charu Kaushic Canada 34 592 0.5× 1.1k 1.0× 1.2k 1.1× 713 1.2× 1.9k 3.3× 91 3.8k
Francis K. Lee United States 26 1.1k 0.8× 467 0.4× 2.6k 2.4× 636 1.0× 609 1.1× 46 4.0k
Audrey L. French United States 36 1.8k 1.4× 633 0.6× 1.7k 1.6× 926 1.5× 359 0.6× 183 4.5k
Eric Sandström Sweden 35 1.6k 1.3× 743 0.7× 1.2k 1.1× 1.7k 2.7× 917 1.6× 169 3.9k
Richard M. Novak United States 29 1.6k 1.3× 347 0.3× 1.2k 1.1× 1.2k 2.0× 391 0.7× 76 3.3k
Katharine J Looker United Kingdom 20 660 0.5× 510 0.4× 2.3k 2.1× 395 0.6× 456 0.8× 39 3.2k

Countries citing papers authored by Marla J. Keller

Since Specialization
Citations

This map shows the geographic impact of Marla J. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marla J. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marla J. Keller more than expected).

Fields of papers citing papers by Marla J. Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marla J. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marla J. Keller. The network helps show where Marla J. Keller may publish in the future.

Co-authorship network of co-authors of Marla J. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Marla J. Keller. A scholar is included among the top collaborators of Marla J. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marla J. Keller. Marla J. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Lounsbury, David W., et al.. (2024). Moving from prove to improve: A collaborative continuous quality improvement process for advancing Clinical and Translational Science. Journal of Clinical and Translational Science. 8(1). e103–e103. 2 indexed citations
4.
Murphy, Kerry, Sujatha Srinivasan, Tao Wang, et al.. (2023). IgA coating of vaginal bacteria is reduced in the setting of bacterial vaginosis (BV) and preferentially targets BV-associated species. Infection and Immunity. 92(1). e0037323–e0037323. 7 indexed citations
5.
Fazzari, Melissa, et al.. (2023). Using K-Means Clustering to Identify Physician Clusters by Electronic Health Record Burden and Efficiency. Telemedicine Journal and e-Health. 30(2). 585–594. 2 indexed citations
6.
Pierce, Carl A., Sharlene Sy, Benjamin Galen, et al.. (2021). Natural mucosal barriers and COVID-19 in children. JCI Insight. 6(9). 89 indexed citations
7.
Pierce, Carl A., Paula Preston‐Hurlburt, Yile Dai, et al.. (2020). Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Science Translational Medicine. 12(564). 213 indexed citations
8.
Murphy, Kerry, Marla J. Keller, Kathryn Anastos, et al.. (2019). Impact of reproductive aging on the vaginal microbiome and soluble immune mediators in women living with and at-risk for HIV infection. PLoS ONE. 14(4). e0216049–e0216049. 23 indexed citations
9.
Aroniadis, Olga C., Lawrence J. Brandt, Caterina Oneto, et al.. (2019). Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. ˜The œLancet. Gastroenterology & hepatology. 4(9). 675–685. 102 indexed citations
10.
Ursell, Luke K., Manjula Gunawardana, John A. Moss, et al.. (2013). Comparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings. Antiviral Research. 102. 87–94. 20 indexed citations
11.
Herold, Betsy C., Marla J. Keller, Qiuhu Shi, et al.. (2013). Plasma and Mucosal HIV Viral Loads Are Associated With Genital Tract Inflammation in HIV-Infected Women. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(4). 485–493. 29 indexed citations
12.
Straten, Ariane van der, Helen Cheng, Barbara Mensch, et al.. (2013). Evaluation of 3 Approaches for Assessing Adherence to Vaginal Gel Application in Clinical Trials. Sexually Transmitted Diseases. 40(12). 950–956. 12 indexed citations
13.
Peipert, Jeffrey F., Qiuhong Zhao, Tracey E. Wilson, et al.. (2012). Trends in Contraceptive Use Among Women With Human Immunodeficiency Virus. Obstetrics and Gynecology. 120(4). 783–790. 35 indexed citations
14.
Keller, Marla J., Amanda Malone, Colleen Carpenter, et al.. (2012). Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring. Journal of Antimicrobial Chemotherapy. 67(8). 2005–2012. 18 indexed citations
15.
Verma, Natasha, et al.. (2011). Topical Prophylaxis for HIV Prevention in Women: Becoming a Reality. Current HIV/AIDS Reports. 8(2). 104–113. 6 indexed citations
16.
Jang, James J., et al.. (2010). Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross‐sectional study. Journal of the International AIDS Society. 13(1). 12–12. 9 indexed citations
17.
Galen, Benjamin, Wuyuan Lu, Wei Wang, et al.. (2006). Human α- and β-Defensins Block Multiple Steps in Herpes Simplex Virus Infection. The Journal of Immunology. 177(12). 8658–8666. 215 indexed citations
18.
Tuyama, Ana C., Natalia Cheshenko, Marı́a J. Carlucci, et al.. (2006). ACIDFORM Inactivates Herpes Simplex Virus and Prevents Genital Herpes in a Mouse Model: Optimal Candidate for Microbicide Combinations. The Journal of Infectious Diseases. 194(6). 795–803. 51 indexed citations
19.
Keller, Marla J., et al.. (2005). Role of Mucosal Immunity in Preventing Genital Herpes Infection. Viral Immunology. 18(4). 595–606. 28 indexed citations
20.
Cohen, Mary Ann, et al.. (2003). Treatment of Interferon-Induced Psychosis in Patients With Comorbid Hepatitis C and HIV. Psychosomatics. 44(5). 417–420. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jo‐Ann S. Passmore Breakdown of academic impact, for papers by Adam Burgener Breakdown of academic impact, for papers by Heather B. Jaspan Breakdown of academic impact, for papers by J. Neil Simonsen Breakdown of academic impact, for papers by Charu Kaushic Breakdown of academic impact, for papers by Francis K. Lee Breakdown of academic impact, for papers by Audrey L. French Breakdown of academic impact, for papers by Eric Sandström Breakdown of academic impact, for papers by Richard M. Novak Breakdown of academic impact, for papers by Katharine J Looker
Rankless by CCL
2026